Rticc
Seleccione idioma:  
Buscar:
RTICC 2013
Programas RTICC
Agenda
Seguimiento cientifico
Sequimiento científico » Publicaciones
 
PUBLICACIONES
RD12/0036/0023
NOTCH1, TP53, and MAP2K1 Mutations in Splenic Diffuse Red Pulp Small B-cell Lymphoma Are Associated With Progressive Disease.
Martinez D, Navarro A, Martinez-Trillos A, Molina-Urra R, Gonzalez-Farre B, Salaverria I, Nadeu F, Enjuanes A, Clot G, Costa D, Carrio A, Villamor N, Colomer D, Martinez A, Bens S, Siebert R, Wotherspoon A, Beà S, Matutes E, Campo E
Am J Surg Pathol  2016.  2.  192-201.  PMID: 26426381. 
Grupos colaboradores: RD12/0036/0036 , RD12/0036/0023

RD12/0036/0023
Present and future of personalized medicine in CLL.
Montserrat E, Bauman T, Delgado J
Best Pract Res Clin Haematol  2016.  1.  100-110.  PMID: 27742064. 

RD12/0036/0023
Maintenance therapy in chronic lymphocytic leukaemia.
Delgado J, Montserrat E
Lancet Haematol  2016.  9.  e399-400.  PMID: 27570083. 

RD12/0036/0023
[Advances in the treatment of chronic lymphocytic leukaemia].
Mozas P, Delgado J
Med Clin (Barc)  2016.  10.  447-454.  PMID: 27431885. 

RD12/0036/0023
The biology behind B-cell lymphoma 2 as a target in chronic lymphocytic leukemia.
Ortíz-Maldonado V, Mozas P, Delgado J
Ther Adv Hematol  2016.  6.  321-329.  PMID: 27904736. 

RD12/0036/0023
The European Hematology Association Roadmap for European Hematology Research: a consensus document.
Engert A, Balduini C, Brand A, Coiffier B, Cordonnier C, Döhner H, de Wit TD, Eichinger S, Fibbe W, Green T, de Haas F, Iolascon A, Jaffredo T, Rodeghiero F, Salles G, Schuringa JJ, EHA Roadmap for European Hematology Research.
Haematologica  2016.  2.  115-208.  PMID: 26819058. 

RD12/0036/0023
Diffuse Large B-Cell Lymphoma: Should Limited-Stage Patients Be Treated Differently?
Giné E, Sehn LH
Hematol Oncol Clin North Am  2016.  6.  1179-1194.  PMID: 27888874. 

RD12/0036/0023
Decoding the DNA Methylome of Mantle Cell Lymphoma in the Light of the Entire B Cell Lineage.
Queirós AC, Beekman R, Vilarrasa-Blasi R, Duran-Ferrer M, Clot G, Merkel A, Raineri E, Russiñol N, Castellano G, Beà S, Navarro A, Kulis M, Verdaguer-Dot N, Jares P, Enjuanes A, Calasanz MJ, Bergmann A, Vater I, Salaverría I, van de Werken HJ, Wilson WH, Datta A, Flicek P, Royo R, Martens J, Giné E, Lopez-Guillermo A, Stunnenberg HG, Klapper W, Pott C, Heath S, Gut IG, Siebert R, Campo E, Martín-Subero JI
Cancer Cell  2016.  5.  806-821.  PMID: 27846393. 
Grupos colaboradores: RD12/0036/0063 , RD12/0036/0036 , RD12/0036/0023

RD12/0036/0023
Genetic evolution in chronic lymphocytic leukaemia.
Delgado J, Villamor N, López-Guillermo A, Campo E
Best Pract Res Clin Haematol  2016.  1.  67-78.  PMID: 27742073. 
Grupos colaboradores: RD12/0036/0036 , RD12/0036/0023

RD12/0036/0020
FEMALE NEWBORN WITH UNDIFFERENTIATED SARCOMA DEFINED BY BCORCCNB3 FUSION TRANSCRIPT
Martín-Vañó S, Berbegall AP, Navarro L, Blanquer-Maceiras M, Beléndez-Bieler C, Garrido-Colino C, Navarro S, Rosa Noguera Salvá
  2015. 

RD12/0036/0020
Tumor Microenvironment Heterogeneity: A Review of the Biology Masterpiece, Evaluation Systems, and Therapeutic Implications
Irene Tadeo, Tomás Álvaro, Samuel Navarro and Rosa Noguera
  2016. 

RD12/0036/0020
Cicatrización de heridas: angiogénesis, linfangiogénesis y fibronectina
CELIA BORJA ALMARCHA, ROSA NOGUERA SALVÁ
  2016. 

RD12/0036/0020
Defining Ewing and Ewing-like small round cell tumors (SRCT): The need for molecular techniques in their categorization and differential diagnosis. A study of 200 cases.
Machado I, Navarro L, Pellin A, Navarro S, Agaimy A, Tardío JC, Karseladze A, Petrov S, Scotlandi K, Picci P, Llombart-Bosch A
Ann Diagn Pathol  2016.  25-32.  PMID: 27180056. 

RD12/0036/0020
Ewing sarcoma and the new emerging Ewing-like sarcomas: (CIC and BCOR-rearranged-sarcomas). A systematic review.
Machado I, Navarro S, Llombart-Bosch A
Histol Histopathol  2016.  11.  1169-81.  PMID: 27306060. 

RD12/0036/0020
The utility of SATB2 immunohistochemical expression in distinguishing between osteosarcomas and their malignant bone tumor mimickers, such as Ewing sarcomas and chondrosarcomas.
Machado I, Navarro S, Picci P, Llombart-Bosch A
Pathol Res Pract  2016.  9.  811-6.  PMID: 27465835. 

RD12/0036/0020
Epigenetic changes in localized gastric cancer: the role of RUNX3 in tumor progression and the immune microenvironment.
Llorca-Cardeñosa MJ, Fleitas T, Ibarrola-Villava M, Peña-Chilet M, Mongort C, Martinez-Ciarpaglini C, Navarro L, Gambardella V, Castillo J, Roselló S, Navarro S, Ribas G, Cervantes A
Oncotarget  2016.  PMID: 27566570. 

RD12/0036/0020
Tumor Microenvironment Heterogeneity: A Review of the Biology Masterpiece, Evaluation Systems, and Therapeutic Implications
Irene Tadeo, Tomás Álvaro, Samuel Navarro and Rosa Noguera
  2016. 

RD12/0036/0020
Tumor de Wilms: estudio morfológico, inmunohistoquímico y genético de un caso de nefroblastoma con diferenciación rabdomioblástica
Julián Boix, Rosa Noguera, Ana P. Berbegall, Susana Martín-Vañó, Vanessa Pérez-Alonso y Samuel Navarro
  2016. 

RD12/0036/0020
Methyl-CpG-binding domain sequencing reveals a prognostic methylation signature in neuroblastoma.
Decock A, Ongenaert M, Cannoodt R, Verniers K, De Wilde B, Laureys G, Van Roy N, Berbegall AP, Bienertova-Vasku J, Bown N, Clément N, Combaret V, Haber M, Hoyoux C, Murray J, Noguera R, Pierron G, Schleiermacher G, Schulte JH, Stallings RL, Tweddle DA, Children?s Cancer and Leukaemia Group (CCLG)., De Preter K, Speleman F, Vandesompele J
Oncotarget  2016.  2.  1960-72.  PMID: 26646589. 

RD12/0036/0020
The genetic tumor background is an important determinant for heterogeneous MYCN-amplified neuroblastoma.
Bogen D, Brunner C, Walder D, Ziegler A, Abbasi R, Ladenstein RL, Noguera R, Martinsson T, Amann G, Schilling FH, Ussowicz M, Benesch M, Ambros PF, Ambros IM
Int J Cancer  2016.  1.  153-63.  PMID: 26910568. 

RD12/0036/0020
Vascular patterns provide therapeutic targets in aggressive neuroblastic tumors.
Tadeo I, Bueno G, Berbegall AP, Fernández-Carrobles MM, Castel V, García-Rojo M, Navarro S, Noguera R
Oncotarget  2016.  15.  19935-47.  PMID: 26918726. 

RD12/0036/0020
Genetic features of neuroblastic tumors associated with opsoclonus-myoclonus syndrome opens up the possibility for detection in peripheral blood.
Berbegall AP, López-Almaraz R, Navarro S, Noguera R
Expert Rev Neurother  2016.  5.  465-7.  PMID: 26949993. 

RD12/0036/0020
Neuroblastoma patient-derived orthotopic xenografts reflect the microenvironmental hallmarks of aggressive patient tumours.
Braekeveldt N, Wigerup C, Tadeo I, Beckman S, Sandén C, Jönsson J, Erjefält JS, Berbegall AP, Börjesson A, Backman T, Øra I, Navarro S, Noguera R, Gisselsson D, Påhlman S, Bexell D
Cancer Lett  2016.  2.  384-9.  PMID: 27000989. 
Grupos colaboradores: RD12/0036/0027 , RD12/0036/0020

RD12/0036/0020
Diagnostic implications of intrapatient genetic tumor heterogeneity.
Berbegall AP, Navarro S, Noguera R
Mol Cell Oncol  2015.  2.  e1079671.  PMID: 27308602. 

RD12/0036/0020
Extracellular matrix composition defines an ultra-high-risk group of neuroblastoma within the high-risk patient cohort.
Tadeo I, Berbegall AP, Castel V, García-Miguel P, Callaghan R, Påhlman S, Navarro S, Noguera R
Br J Cancer  2016.  4.  480-9.  PMID: 27415013. 

RD12/0036/0020
Stage 4S neuroblastoma tumors show a characteristic DNA methylation portrait.
Decock A, Ongenaert M, De Wilde B, Brichard B, Noguera R, Speleman F, Vandesompele J
Epigenetics  2016.  0.  PMID: 27599161. 

RD12/0036/0031
Lynch syndrome caused by germline PMS2 mutations: delineating the cancer risk.
ten Broeke SW, Brohet RM, Tops CM, van der Klift HM, Velthuizen ME, Bernstein I, Capellá Munar G, Gomez Garcia E, Hoogerbrugge N, Letteboer TG, Menko FH, Lindblom A, Mensenkamp AR, Moller P, van Os TA, Rahner N, Redeker BJ, Sijmons RH, Spruijt L, Suerink M, Vos YJ, Wagner A, Hes FJ, Vasen HF, Nielsen M, Wijnen JT
J Clin Oncol  2015.  4.  319-25.  PMID: 25512458. 

RD12/0036/0031
The effect of genotypes and parent of origin on cancer risk and age of cancer development in PMS2 mutation carriers.
Suerink M, van der Klift HM, Ten Broeke SW, Dekkers OM, Bernstein I, Capellá Munar G, Gomez Garcia E, Hoogerbrugge N, Letteboer TG, Menko FH, Lindblom A, Mensenkamp A, Moller P, van Os TA, Rahner N, Redeker BJ, Olderode-Berends MJ, Spruijt L, Vos YJ, Wagner A, Morreau H, Hes FJ, Vasen HF, Tops CM, Wijnen JT, Nielsen M
Genet Med  2016.  4.  405-9.  PMID: 26110232. 

RD12/0036/0031
Delineating the Phenotypic Spectrum of the NTHL1-Associated Polyposis.
Belhadj S, Mur P, Navarro M, González S, Moreno V, Capellá G, Valle L
Clin Gastroenterol Hepatol  2016.  PMID: 27720914. 
Grupos colaboradores: RD12/0036/0009 , RD12/0036/0031

RD12/0036/0031
Mutanome and expression of immune response genes in microsatellite stable colon cancer.
Sanz-Pamplona R, Gil-Hoyos R, López-Doriga A, Alonso MH, Aussó S, Molleví DG, Santos C, Sanjuán X, Salazar R, Alemany R, Moreno V
Oncotarget  2016.  14.  17711-25.  PMID: 26871478. 

RD12/0036/0031
A Vulnerability of a Subset of Colon Cancers with Potential Clinical Utility.
Vecchione L, Gambino V, Raaijmakers J, Schlicker A, Fumagalli A, Russo M, Villanueva A, Beerling E, Bartolini A, Mollevi DG, El-Murr N, Chiron M, Calvet L, Nicolazzi C, Combeau C, Henry C, Simon IM, Tian S, in 't Veld S, D'ario G, Mainardi S, Beijersbergen RL, Lieftink C, Linn S, Rumpf-Kienzl C, Delorenzi M, Wessels L, Salazar R, Di Nicolantonio F, Bardelli A, van Rheenen J, Medema RH, Tejpar S, Bernards R
Cell  2016.  2.  317-30.  PMID: 27058664. 

RD12/0036/0031
Gastrointestinal cancer: Light and shade of intrahepatic arterial radiotherapy in mCRC.
Tabernero J, Salazar R
Nat Rev Clin Oncol  2016.  8.  467-8.  PMID: 27296298. 
Grupos colaboradores: RD12/0036/0012 , RD12/0036/0031

RD12/0036/0031
Synthetic lethal interaction of cetuximab with MEK1/2 inhibition in NRAS-mutant metastatic colorectal cancer.
Queralt B, Cuyàs E, Bosch-Barrera J, Massaguer A, de Llorens R, Martin-Castillo B, Brunet J, Salazar R, Menendez JA
Oncotarget  2016.  PMID: 27636997. 

RD12/0036/0031
A novel germline POLE mutation causes an early onset cancer prone syndrome mimicking constitutional mismatch repair deficiency.
Wimmer K, Beilken A, Nustede R, Ripperger T, Lamottke B, Ure B, Steinmann D, Reineke-Plaass T, Lehmann U, Zschocke J, Valle L, Fauth C, Kratz CP
Fam Cancer  2016.  PMID: 27573199. 

RD12/0036/0031
Recent discoveries in the genetics of familial colorectal cancer and polyposis.
Valle L
Clin Gastroenterol Hepatol  2016.  PMID: 27712984. 

RD12/0036/0031
AMER1 Is a Frequently Mutated Gene in Colorectal Cancer--Letter.
Mur P, Aiza G, Sanz-Pamplona R, González S, Navarro M, Moreno V, Capellá G, Valle L
Clin Cancer Res  2015.  21.  4985.  PMID: 26527806. 

RD12/0036/0031
Incidence of and survival after subsequent cancers in carriers of pathogenic MMR variants with previous cancer: a report from the prospective Lynch syndrome database.
Møller P, Seppälä T, Bernstein I, Holinski-Feder E, Sala P, Evans DG, Lindblom A, Macrae F, Blanco I, Sijmons R, Jeffries J, Vasen H, Burn J, Nakken S, Hovig E, Rødland EA, Tharmaratnam K, de Vos Tot Nederveen Cappel WH, Hill J, Wijnen J, Jenkins M, Green K, Lalloo F, Sunde L, Mints M, Bertario L, Pineda M, Navarro M, Morak M, Renkonen-Sinisalo L, Frayling IM, Plazzer JP, Pylvanainen K, Genuardi M, Mecklin JP, Möslein G, Sampson JR, Capella G, Mallorca Group (http://mallorca-group.org).
Gut  2016.  PMID: 27261338. 
Grupos colaboradores: RD12/0036/0009 , RD12/0036/0031

RD12/0036/0031
Scarce evidence of the causal role of germline mutations in UNC5C in hereditary colorectal cancer and polyposis.
Mur P, Sánchez-Cuartielles E, Aussó S, Aiza G, Valdés-Mas R, Pineda M, Navarro M, Brunet J, Urioste M, Lázaro C, Moreno V, Capellá G, Puente XS, Valle L
Sci Rep  2016.  20697.  PMID: 26852919. 
Grupos colaboradores: RD12/0036/0009 , RD12/0036/0008 , RD12/0036/0031

RD12/0036/0069
Tacrolimus plus sirolimus with or without ATG as GVHD prophylaxis in HLA-mismatched unrelated donor allogeneic stem cell transplantation.
Kharfan-Dabaja MA, Parody R, Perkins J, Lopez-Godino O, Lopez-Corral L, Vazquez L, Caballero D, Falantes J, Shapiro J, Ortí G, Barba P, Valcárcel D, Esquirol A, Martino R, Piñana JL, Solano C, Tsalatsanis A, Pidala J, Anasetti C, Perez-Simón JA
Bone Marrow Transplant  2016.  PMID: 27819684. 
Grupos colaboradores: RD12/0036/0060 , RD12/0036/0069 , RD12/0036/0014 , RD12/0036/0061

RD12/0036/0034
Somatic mosaicism: on the road to cancer.
Fernández LC, Torres M, Real FX
  2016. 

RD12/0036/0023
Yellow urticaria: report of two cases and review of the literature.
Combalia A, Fustà X, Guilabert A, Mascaró JM Jr, Estrach T
J Eur Acad Dermatol Venereol  2016.  PMID: 27579904. 

RD12/0036/0026
Opposing roles of TGF-? and EGF in the regulation of TRAIL-induced apoptosis in human breast epithelial cells.
Cano-González A, López-Rivas A
Biochim Biophys Acta  2016.  8.  2104-14.  PMID: 27208428. 

RD12/0036/0026
Autophagy requires poly(adp-ribosyl)ation-dependent AMPK nuclear export.
Rodríguez-Vargas JM, Rodríguez MI, Majuelos-Melguizo J, García-Diaz Á, González-Flores A, López-Rivas A, Virág L, Illuzzi G, Schreiber V, Dantzer F, Oliver FJ
Cell Death Differ  2016.  PMID: 27689873. 

RD12/0036/0031
APC promoter is frequently methylated in pancreatic juice of patients with pancreatic carcinomas or periampullary tumors.
Ginesta MM, Diaz-Riascos ZV, Busquets J, Pelaez N, Serrano T, Peinado MÀ, Jorba R, García-Borobia FJ, Capella G, Fabregat J
Oncol Lett  2016.  3.  2210-2216.  PMID: 27602165. 

RD12/0036/0031
Carcinoma-associated fibroblasts affect sensitivity to oxaliplatin and 5FU in colorectal cancer cells.
Gonçalves-Ribeiro S, Guillen Díaz-Maroto N, Berdiel-Acer M, Soriano A, Guardiola J, Martínez-Villacampa M, Salazar R, Capellà G, Villanueva A, Martínez-Balibrea E, Molleví DG
Oncotarget  2016.  PMID: 27517495. 

RD12/0036/0031
Genomic Landscape of Colorectal Mucosa and Adenomas.
Borras E, San Lucas FA, Chang K, Zhou R, Masand G, Fowler J, Mork ME, You YN, Taggart MW, McAllister F, Jones DA, Davies GE, Edelmann W, Ehli EA, Lynch PM, Hawk ET, Capella G, Scheet P, Vilar E
Cancer Prev Res (Phila)  2016.  6.  417-27.  PMID: 27221540. 

RD12/0036/0031
Identification of a founder BRCA1 mutation in the Moroccan population.
Quiles F, Teulé À, Martinussen Tandstad N, Feliubadaló L, Tornero E, Del Valle J, Menéndez M, Salinas M, Wethe Rognlien V, Velasco A, Izquierdo A, Capellá G, Brunet J, Lázaro C
Clin Genet  2016.  4.  361-5.  PMID: 26864382. 
Grupos colaboradores: RD12/0036/0008 , RD12/0036/0031

RD12/0036/0031
Investigating the effect of 28 BRCA1 and BRCA2 mutations on their related transcribed mRNA.
Quiles F, Menéndez M, Tornero E, del Valle J, Teulé À, Palanca S, Izquierdo A, Gómez C, Campos O, Santamaria R, Brunet J, Capellá G, Feliubadaló L, Lázaro C
Breast Cancer Res Treat  2016.  2.  253-60.  PMID: 26780556. 
Grupos colaboradores: RD12/0036/0008 , RD12/0036/0031

RD12/0036/0025
Facilitated Anion Transport Induces Hyperpolarization of the Cell Membrane That Triggers Differentiation and Cell Death in Cancer Stem Cells
Soto-Cerrato V, Manuel-Manresa P, Hernando E, Calabuig-Fariñas S, Martínez-Romero A, Fernández-Dueñas V, Sahlholm K, Knöpfel T, García-Valverde M, Rodilla AM, Jantus-Lewintre E, Farràs R, Ciruela F, Pérez-Tomás R, Quesada R
  2015.  PMID: 26632983. 

RD12/0036/0025
Serum metabolomic profiling facilitates the non-invasive identification of metabolic biomarkers associated with the onset and progression of non-small cell lung cancer
Puchades-Carrasco, L ; Jantus-Lewintre, E ; Perez-Rambla, C ; Garcia-Garcia, F; Lucas, R ; Calabuig, S ; Blasco, A ; Dopazo, J ; Camps, C ; Pineda-Lucena, A
  2016.  PMID: 26883203. 

Acceso a la aplicación
Publicaciones
Proyectos
Guías Clínicas
Ensayos Clínicos
Cursos
Conferencias & Activ. difusión
Guía uso aplicación
Noticias
03/03/2017 | Otras reuniones
13/11/2016 | Otras reuniones
Publicaciones
RD12/0036/0023
NOTCH1, TP53, and MAP2K1 Mutations in Splenic Diffuse Red Pulp Small B-cell Lymphoma Are Associated With Progressive Disease.
Martinez D, Navarro A, Martinez-Trillos A, Molina-Urra R, Gonzalez-Farre B, Salaverria I, Nadeu F, Enjuanes A, Clot G, Costa D, Carrio A, Villamor N, Colomer D, Martinez A, Bens S, Siebert R, Wotherspoon A, Beà S, Matutes E, Campo E
Am J Surg Pathol  2016.  2.  192-201.  PMID: 26426381. 
Grupos colaboradores: RD12/0036/0036 , RD12/0036/0023

RD12/0036/0023
Present and future of personalized medicine in CLL.
Montserrat E, Bauman T, Delgado J
Best Pract Res Clin Haematol  2016.  1.  100-110.  PMID: 27742064. 

RD12/0036/0023
Maintenance therapy in chronic lymphocytic leukaemia.
Delgado J, Montserrat E
Lancet Haematol  2016.  9.  e399-400.  PMID: 27570083. 

RD12/0036/0023
[Advances in the treatment of chronic lymphocytic leukaemia].
Mozas P, Delgado J
Med Clin (Barc)  2016.  10.  447-454.  PMID: 27431885. 

RD12/0036/0023
The biology behind B-cell lymphoma 2 as a target in chronic lymphocytic leukemia.
Ortíz-Maldonado V, Mozas P, Delgado J
Ther Adv Hematol  2016.  6.  321-329.  PMID: 27904736. 

RD12/0036/0023
The European Hematology Association Roadmap for European Hematology Research: a consensus document.
Engert A, Balduini C, Brand A, Coiffier B, Cordonnier C, Döhner H, de Wit TD, Eichinger S, Fibbe W, Green T, de Haas F, Iolascon A, Jaffredo T, Rodeghiero F, Salles G, Schuringa JJ, EHA Roadmap for European Hematology Research.
Haematologica  2016.  2.  115-208.  PMID: 26819058. 

RD12/0036/0023
Diffuse Large B-Cell Lymphoma: Should Limited-Stage Patients Be Treated Differently?
Giné E, Sehn LH
Hematol Oncol Clin North Am  2016.  6.  1179-1194.  PMID: 27888874. 

RD12/0036/0023
Decoding the DNA Methylome of Mantle Cell Lymphoma in the Light of the Entire B Cell Lineage.
Queirós AC, Beekman R, Vilarrasa-Blasi R, Duran-Ferrer M, Clot G, Merkel A, Raineri E, Russiñol N, Castellano G, Beà S, Navarro A, Kulis M, Verdaguer-Dot N, Jares P, Enjuanes A, Calasanz MJ, Bergmann A, Vater I, Salaverría I, van de Werken HJ, Wilson WH, Datta A, Flicek P, Royo R, Martens J, Giné E, Lopez-Guillermo A, Stunnenberg HG, Klapper W, Pott C, Heath S, Gut IG, Siebert R, Campo E, Martín-Subero JI
Cancer Cell  2016.  5.  806-821.  PMID: 27846393. 
Grupos colaboradores: RD12/0036/0063 , RD12/0036/0036 , RD12/0036/0023

RD12/0036/0023
Genetic evolution in chronic lymphocytic leukaemia.
Delgado J, Villamor N, López-Guillermo A, Campo E
Best Pract Res Clin Haematol  2016.  1.  67-78.  PMID: 27742073. 
Grupos colaboradores: RD12/0036/0036 , RD12/0036/0023

RD12/0036/0020
FEMALE NEWBORN WITH UNDIFFERENTIATED SARCOMA DEFINED BY BCORCCNB3 FUSION TRANSCRIPT
Martín-Vañó S, Berbegall AP, Navarro L, Blanquer-Maceiras M, Beléndez-Bieler C, Garrido-Colino C, Navarro S, Rosa Noguera Salvá
  2015. 

ISCII
ISCII
 
Ministerio de Economia y Competitividad
Descargar
Red Temática Investigación Cooperativa Sanitaria
Rticc 2012
Logotipos
 
ISCII
Red Temática Investigación Cooperativa en Cáncer (RTICC)
Centro de Investigación Cáncer - Campus Miguel de Unamuno - 37007 - Salamanca
(+34) 923294803 - sec.rticc[arroba]usal.es
|
|
|
|
 
Sobre la RTICC Programas RTICC Ofertas de empleo y Agenda Seguimiento científico
Red Temática de Investigación Cooperativa en Cáncer · © Copyright 2013 · sec.rticc[arrroba]usal.es · diseño web: detrazos
RSS